Literature DB >> 11848690

Perspectives of B-mode transcranial ultrasound.

Daniela Berg1, Georg Becker.   

Abstract

Transcranial color coded sonography has proved valuable in the diagnostic work-up of cerebrovascular disorders in adults. More recently, evidences have converged that transcranial sonography is also useful in the diagnosis of brain parenchymal disorders. Here, a new field of application is the visualization of signal intensity shift in specific brain areas in some neurodegenerative disorders (Parkinson's disease, idiopathic dystonia, and depression). Findings obtained by transcranial ultrasound complement information from other neuroimaging data in these disorders and have led to the generation of new pathophysiological concepts. In this review we summarize the application fields of transcranial sonography with special emphasis on recent findings in neurodegenerative disorders and their implications for future research. As new application and processing techniques are being developed transcranial color coded sonography will gain increasing impact on both diagnosis and research of neurological disorders. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 11848690     DOI: 10.1006/nimg.2001.1014

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  6 in total

Review 1.  Early diagnosis of Parkinson's disease.

Authors:  Jörg Spiegel; Alexander Storch; Wolfgang H Jost
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

2.  Spectral image reconstruction for transcranial ultrasound measurement.

Authors:  Greg T Clement
Journal:  Phys Med Biol       Date:  2005-11-16       Impact factor: 3.609

Review 3.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

4.  Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity.

Authors:  K J Schweitzer; S Behnke; I Liepelt; B Wolf; C Grosser; J Godau; A Gaenslen; T Bruessel; A Wendt; F Abel; A Müller; T Gasser; D Berg
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

5.  Biopsable neural tissues: toward new biomarkers for Parkinson's disease?

Authors:  Thibaud Lebouvier; Maddalena Tasselli; Sébastien Paillusson; Hélène Pouclet; Michel Neunlist; Pascal Derkinderen
Journal:  Front Psychiatry       Date:  2010-09-03       Impact factor: 4.157

Review 6.  Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.

Authors:  Daniela Berg; Helmine Hochstrasser; Katherine J Schweitzer; Olaf Riess
Journal:  Neurotox Res       Date:  2006-01       Impact factor: 3.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.